Trials / Recruiting
RecruitingNCT04650321
Home Based Infusions for Ocrelizumab
Evaluating the Feasibility of Pandemic Forward, Telehealth Based Home Based Infusions
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The goal is to assess the safety and effectiveness of home ocrelizumab infusion.
Detailed description
The safety of home ocrelizumab infusion will be assessed by monitoring for infusion reactions and adverse events, and comparing proportions/rates to existing studies. Patient reported outcomes (PROs) will compare pre to post infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ocrelizumab at home | Patients will receive ocrelizumab infusion at home. |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-08-31
- Completion
- 2021-08-31
- First posted
- 2020-12-02
- Last updated
- 2021-06-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04650321. Inclusion in this directory is not an endorsement.